K2 (avril 2027)/ CME GLOBEX
K2- - | Chg. - | Ouverture | Haut | Bas | Précédent Fermer |
---|---|---|---|---|---|
-USD | - | - | - | - | - |
GlobeNewswire
02:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page